Unrecognized Tax Benefits in USD of Vanda Pharmaceuticals Inc. from Q4 2016 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Vanda Pharmaceuticals Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2016 to Q4 2024.
Vanda Pharmaceuticals Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $18.8M, a 2.64% increase year-over-year.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Vanda Pharmaceuticals Inc. Quarterly Unrecognized Tax Benefits (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$18.8M	+$484K	+2.64%	Dec 31, 2024	10-K	2025-02-14
Q4 2023	$18.3M	+$2.83M	+18.3%	Dec 31, 2023	10-K	2025-02-14
Q4 2022	$15.5M	+$2.55M	+19.7%	Dec 31, 2022	10-K	2025-02-14
Q4 2021	$12.9M	+$1.7M	+15.2%	Dec 31, 2021	10-K	2025-02-14
Q4 2020	$11.2M	+$1.49M	+15.3%	Dec 31, 2020	10-K	2024-02-08
Q4 2019	$9.74M	+$9.74M		Dec 31, 2019	10-K	2023-02-09
Q3 2019	$9.7M			Sep 30, 2019	10-Q	2019-11-07
Q4 2018	$0	$0		Dec 31, 2018	10-K	2022-02-24
Q4 2017	$0	$0		Dec 31, 2017	10-K	2021-02-11
Q4 2016	$0			Dec 31, 2016	10-K	2020-02-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.